Hem › Smoldering multipelt myelom › New York
Kliniska studier för Smoldering multipelt myelom i New York
8 studier för Smoldering multipelt myelom söker deltagare vid platser i New York.
Städer i New York
Officiell studietext (engelska)
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Memorial Sloan Kettering Cancer Center, New York
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Hematology Oncology Associates of CNY at Camillus, Camillus
- Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
- Mount Sinai Chelsea, New York
- och 2 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT03937635A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- NYU Langone Health Perlmutter Cancer Center, New York
- Stony Brook University Hospital, Stony Brook
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 8 juli 2026 · NCT06140524A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 16 apr. 2026 · NCT05640843Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- Roswell Park Cancer Institute, Buffalo
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 1 dec. 2025 · NCT05312255A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 13 nov. 2025 · NCT06055894Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RekryterarObservationsstudie
Ålder 40 och äldre · Alla kön · Uppdaterad 6 aug. 2025 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
- University of Rochester, Rochester
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 10 feb. 2025 · NCT05597345Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.